Clinical Trial Update: Confirmatory Study of Govorestat in CMT-SORD [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 confirmatory study of Govorestat for Charcot-Marie-Tooth disease with sorbitol dehydrogenase deficiency (CMT-SORD),…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease

Drugs mentioned

• Govorestat (Govorestat)

Snippet

Sponsor: Applied Therapeutics, Inc. | Conditions: Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD) | Phase 3 | Status: NOT_YET_RECRUITING